VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Evopoint Biosciences Files for STAR Market IPO Highlighting $1.3B Astellas Deal and Late-Stage Oncology Pipeline
Evopoint Biosciences Files for STAR Market IPO Highlighting $1.3B Astellas Deal and Late-Stage Oncology Pipeline
CST Updated Jun 29, 2026 10:43
Share:
